300676.SZ

BGI Genomics Co., Ltd. [300676.SZ] Stock Forecast

Buy or Sell ? Support and Resistance
What is MACD and how to read it?
How RSI can help?
RSI : 000

300676.SZ Stock Summary

Top 300676.SZ Correlated Resources

300676.SZ

Top 10 Correlated ETFs

300676.SZ

Top 10 Correlated Stocks

300676.SZ

In the News

300676.SZ Financial details

Company Rating
-
Market Cap
15.84B
Income
91.42M
Revenue
4.35B
Book val./share
-
Cash/share
-
Dividend
1
Dividend %
2.28%
Employees
4.45K
Optionable
No
Shortable
Yes
Earnings
29 Feb 2024
P/E
145.73
Forward P/E
-
PEG
-16.43
P/S
3.17
P/B
1.84
P/C
-
P/FCF
-12.54
Quick Ratio
2.38
Current Ratio
2.65
Debt / Equity
-
LT Debt / Equity
-
-
-
EPS (TTM)
0.22
EPS next Y
-
EPS next Q
-
EPS this Y
-88.78%
EPS next Y
-
EPS next 5Y
-
EPS last 5Y
-20.44%
Revenue last 5Y
9.22%
Revenue Q/Q
12.74%
EPS Q/Q
11.89%
-
-
-
-
SMA20
-11.2%
SMA50
-14.07%
SMA100
4.93%
Inst Own
-
Inst Trans
-
ROA
1%
ROE
1%
ROC
0.03%
Gross Margin
48%
Oper. Margin
5%
Profit Margin
2%
Payout
331%
Shs Outstand
-
Shs Float
-
-
-
-
-
Target Price
-
52W Range
33.0-78.43
52W High
-38.12%
52W Low
+46.27%
RSI
41.66
Rel Volume
1.09
Avg Volume
3.34M
Volume
3.63M
Perf Week
-0.37%
Perf Month
-19.55%
Perf Quarter
8.13%
Perf Half Y
4.59%
-
-
-
-
Beta
0.635
-
-
Volatility
0.51%, 3.63%
Prev Close
1.3%
Price
48.27
Change
3.01%

300676.SZ Financial Performance

300676.SZ Dividend History

300676.SZ Frequently Asked Questions

What is BGI Genomics Co., Ltd. stock symbol ?

BGI Genomics Co., Ltd. is a CN stock and trading under the symbol 300676.SZ

What is BGI Genomics Co., Ltd. stock quote today ?

BGI Genomics Co., Ltd. stock price is $48.27 today.

Is BGI Genomics Co., Ltd. stock public?

Yes, BGI Genomics Co., Ltd. is a publicly traded company.

Something similar

Top by Market Cap
LLY.DE
BRK-B
AMZ.DE
DHR-PB
JPM
Top Correlated ETFs
HDRO
HYDR
CQQQ
YINN
PTIN
Top Correlated Stocks
002268.SZ
600640.SS
600100.SS
600271.SS
002063.SZ
Similar Market Cap
600004.SS
601696.SS
SIOFF.OL
HST
600580.SS

Company Profile

Healthcare Medical - Diagnostics & Research
  • Volume Average 3.34M
  • Market Capitalization 15.84B
  • Employee 4.45K
  • CEO Mr. Ye Yin
  • Headquarters Shenzhen,CN
  • IPO Date 2017-07-14
  • Website https://www.bgi.com

BGI Genomics Co., Ltd. provides sequencing services and a portfolio of genetic tests for medical institutions, research institutions, and other public and private partners in China and internationally. The company offers DNA, RNA, and customized sequencing services; and non-invasive prenatal testing, reproductive health screening, newborn genetic screening, and clinical exome sequencing services, as well as clinical and research solutions for oncology. It also offers laboratory solutions for the detection and diagnosis of patients suspected with COVID-19; SARS-CoV-2 IgM and IgG antibody detection kit; and real-time fluorescent RT-PCR kit for detecting SARS-CoV-2. The company offers its services in various research areas, such as agriculture and food science, cancer research, metagenomics, reproductive health, biomarker discovery, and drug discovery. The company was formerly known as Shenzhen BGI Medicine Co., Ltd. and changed its name to BGI Genomics Co., Ltd. in 2015. BGI Genomics Co., Ltd. was founded in 1999 and is headquartered in Shenzhen, China.